Skip to main content
SpringerLink
Log in

DYSLIPIDAEMIA

GPR146 is a potential new therapeutic target for lipid lowering

  • Research Highlight
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Yu, H. et al. GPR146 deficiency protects against hypercholesterolemia and atherosclerosis. Cell 179, 1276–1288.e14 (2019)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Cardiology http://www.nature.com/nrcardio/

    Irene Fernández-Ruiz

Authors
  1. Irene Fernández-Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irene Fernández-Ruiz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández-Ruiz, I. GPR146 is a potential new therapeutic target for lipid lowering. Nat Rev Cardiol 17, 132–133 (2020). https://doi.org/10.1038/s41569-019-0328-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-019-0328-5

  • Springer Nature Limited

Search

Navigation